Synageva BioPharma Corp (NASDAQ:GEVA)

103.51
Delayed Data
As of Apr 17
 -2.45 / -2.31%
Today’s Change
60.19
Today|||52-Week Range
122.88
+11.55%
Year-to-Date
No recent news for Synageva BioPharma Corp.

Today’s Trading

Previous close105.96
Today’s open104.63
Day’s range100.84 - 104.83
Volume356,189
Average volume (3 months)316,123
Market cap$3.8B
Dividend yield--
Data as of 3:59pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)-73.24%
Earnings growth (this year)-27.52%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)-51.46%
P/E ratioNM
Price/Sales467.65
Price/Book7.30

Competitors

 Today’s
change
Today’s
% change
CTLTCatalent Inc-0.52-1.67%
BLUEbluebird bio Inc-1.42-1.06%
XONIntrexon Corp-1.29-2.87%
KITEKite Pharma Inc-0.21-0.32%
Data as of 4:03pm ET, 04/17/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)-$1.71
Annual revenue (last year)$6.5M
Annual profit (last year)-$192.6M
Net profit margin-2,967.47%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sanj K. Patel
Chief Operating Officer
Robert B. Bazemore
Corporate headquarters
Lexington, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers